GlassScriptPhysician profile
Shane M Mesko
NPI 1699137315
$6,769.24
in general payments reported to CMS, 2019-2025
54 companies · $3,646 in 2025
The $3,646 reported for 2025 was more than what 93% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $149 · 2022: $729 · 2023: $580 · 2024: $1,666 · 2025: $3,646.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,165 · Travel and Lodging: $727.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,164.72 |
| Travel and Lodging | $726.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Icotec Medical INC. | $1,079.49 | 2025 | Vader Pedicle System 6.0, Screw, Carbon/Peek, Polyax., Fen., O 5.5 X 45 Mm, Vader Pedicle System, Rod, Carbon/Peek, Curved, 6.0 R450 X 200 Mm, Kong-Tl Vbr, End Plate, Round, L and Screw, 12 X 43 Mm |
| Novocure INC. | $501.21 | 2021-2025 | Optune Gio, Optune |
| Progenics Pharmaceuticals, INC. | $412.16 | 2022-2025 | Pylarify |
| Abbvie INC. | $283.23 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $244.00 | 2023-2025 | Imfinzi |
| Merck Sharp & Dohme LLC | $224.38 | 2025 | Keytruda, Lynparza, Keytruda Qlex |
| Sobi, INC | $199.03 | 2024-2025 | |
| Pharmaessentia USA Corporation | $188.39 | 2024-2025 | Besremi |
| Novartis Pharmaceuticals Corporation | $187.74 | 2024-2025 | |
| Lilly USA, LLC | $181.65 | 2022-2025 | Jaypirca, Verzenio |
| Janssen Biotech, INC. | $178.53 | 2024-2025 | Erleada, Rybrevant |
| Reflexion Medical, INC. | $156.00 | 2024 | Reflexion Medical Radiotherapy System |
| Agios Pharmaceuticals, INC. | $153.38 | 2023-2025 | Pyrukynd |
| Janssen Scientific Affairs, LLC | $147.61 | 2024 | Tremfya |
| Pfizer INC. | $145.74 | 2023-2024 |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shane Mesko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.